Latham & Watkins acted as the lead legal counsel to the consortium led by Todd Boehly, chairman and CEO of Eldridge, and Clearlake Capital Group, L.P....
Clearlake Capital-led Consortium’s Acquisition of Chelsea Football Club
Bain Capital’s Acquisition of VXI Global Solutions
Maples and Calder advised Bain Capital Private Equity on its acquisition of VXI Global Solutions from Carlyle Group Inc. and the financing of the acquisition. BofA...
COVA Acquisition’s $3.82 Billion De-Spac Merger with ECARX
UBS AG Hong Kong Branch(1) and Morgan Stanley Asia Limited acted as joint financial advisors to ECARX. Skadden, Arps, Slate, Meagher & Flom, together with Maples...
Stoneway’s Restructuring
SCC Power was represented in the acquisition and restructuring by Simpson Thacher & Bartlett LLP, Maples and Calder, McCarthy Tétrault LLP, Stewart McKelvey and Tavarone, Rovelli,...
Pfizer’s Acquisition of Biohaven Pharmaceutical
Ropes & Gray, working alongside Walkers, represented Pfizer, while Skadden advised Centerview Partners, the financial advisor to Biohaven Pharmaceutical on the deal. S&C, Maples and Calder...
GoodGreen’s $344 Million Green Bond Issuance
Maples Group provided Cayman Islands legal advice and fiduciary services to GoodGreen 2022-1, the Cayman Islands issuer of US$344 million of Green Bonds backed by a...
Arcos Dorados’ $350 Million Notes Offering and $150 Million Cash Tender Offers
Davis Polk, Maples and Calder, NautaDutilh, O’Neill & Borges, Lefosse and Ritch, Mueller y Nicolau advised Arcos Dorados Holdings in the offering and in the concurrent...
Zhihu’s US$106 Million Hong Kong IPO and Dual Primary Listing
Skadden, Arps, Slate, Meagher & Flom LLP acted as legal advisers to Zhihu as to Hong Kong and US laws and Han Kun Law Offices as...
NIO Inc.’s Secondary Listing in Hong Kong
Maples Group and Skadden, Arps, Slate, Meagher & Flom LLP and Affiliates acted as legal advisers to NIO as to Hong Kong and US laws and...
Yisheng Biopharma Co., Ltd.’s US$40 Million Royalty-Backed Financing From R-Bridge Healthcare Fund
Clifford Chance has advised Yisheng Biopharma Co., Ltd. on the deal, while Sidley Austin LLP and Maples and Calder advised R-Bridge Healthcare Fund. Yisheng Biopharma Co.,...
Primavera Capital Acquisition Corporation’s Business Combination with Lanvin Group
Simpson Thacher and Walkers Global represented Primavera Capital Acquisition Corporation on the deal. DLA Piper, working closely with Maples and Calder, assisted Lanvin. Primavera Capital Acquisition...
Aquila Acquisition Corporation’s $128 Million Listing on Hong Kong Stock Exchange
Baker McKenzie advised CCB (Asia) Trustee Company Limited on the deal. Maples and Calder and Freshfields Bruckhaus Deringer assisted Aquila Acquisition Corporation. Linklaters represented the joint...